2021 issue 2

Back

Volume 37, issue 2

Review article

Relapse prevention in schizophrenia: expectations and reality

Marek Jarema1
1. 3rd Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, Poland
Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (2), 123–135
Date of publication: 15-09-2021
DOI: https://doi.org/10.33450/fpn.2021.06.001
Keywords: schizophrenia, relapse prevention, worsening, treatment

Abstract

Aim. The aim of the paper was to evaluate the practical prospects for preventing from relapsing or worsening in schizophrenia patients.

Selected literature review. Some of the recent publications deal with the prospects for preventing from relapsing or worsening symptoms in patients suffering from schizophrenia. This paper reviews publications highlighting the effectiveness of such prevention measures.

Conclusions. The review revealed that both pharmacological and non-pharmacological methods of treatment may be useful in the clinical improvement of schizophrenia.

Address for correspondence:
Marek Jarema
Institute of Psychiatry and Neurology
3rd Department of Psychiatry
9 Sobieskiego Str.
02-957 Warsaw, Poland
email: jarema@ipin.edu.pl